These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22523317)

  • 21. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
    Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
    J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of CTX-M-15, CTX-M-22, and SHV-2 extended-spectrum beta-lactamases (ESBLs) in Escherichia coli fecal-sample isolates from pig farms in China.
    Tian GB; Wang HN; Zou LK; Tang JN; Zhao YW; Ye MY; Tang JY; Zhang Y; Zhang AY; Yang X; Xu CW; Fu YJ
    Foodborne Pathog Dis; 2009 Apr; 6(3):297-304. PubMed ID: 19272004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CTX-M-producing Escherichia coli in a maternity ward: a likely community importation and evidence of mother-to-neonate transmission.
    Dubois V; De Barbeyrac B; Rogues AM; Arpin C; Coulange L; Andre C; M'zali F; Megraud F; Quentin C
    J Antimicrob Chemother; 2010 Jul; 65(7):1368-71. PubMed ID: 20466850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France.
    Leflon-Guibout V; Blanco J; Amaqdouf K; Mora A; Guize L; Nicolas-Chanoine MH
    J Clin Microbiol; 2008 Dec; 46(12):3900-5. PubMed ID: 18842941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of CTX-M-2-producing Escherichia coli in diseased horses: evidence of genetic exchanges of bla(CTX-M-2) linked to ISCR1.
    Smet A; Boyen F; Flahou B; Doublet B; Praud K; Martens A; Butaye P; Cloeckaert A; Haesebrouck F
    J Antimicrob Chemother; 2012 May; 67(5):1289-91. PubMed ID: 22328640
    [No Abstract]   [Full Text] [Related]  

  • 26. Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway.
    Naseer U; Haldorsen B; Tofteland S; Hegstad K; Scheutz F; Simonsen GS; Sundsfjord A;
    APMIS; 2009 Jul; 117(7):526-36. PubMed ID: 19594493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Asymptomatic and simultaneous fecal carriage of two strains of Escherichia coli expressing CTX-M-1 and CTX-M-14 extended-spectrum betalactamases].
    Rachid S; Harchay C; Ben Othman A; Zribi M; Masmoudi A; Fendri C
    Med Mal Infect; 2012 Mar; 42(3):133-4. PubMed ID: 22405514
    [No Abstract]   [Full Text] [Related]  

  • 28. Dominance of CTX-M-2 and CTX-M-56 among extended-spectrum beta-lactamases produced by Klebsiella pneumoniae and Escherichia coli isolated in hospitals in Paraguay.
    Khan MA; Lemmens N; Riera E; Blonk T; Goedhart J; Van Belkum A; Goessens W; Hays JP; Van Westreenen M
    J Antimicrob Chemother; 2009 Dec; 64(6):1330-2. PubMed ID: 19854861
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G; Costello M; Pitout JD
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of plasmids encoding CMY-2 AmpC beta-lactamases from Escherichia coli in Canadian intensive care units.
    Baudry PJ; Mataseje L; Zhanel GG; Hoban DJ; Mulvey MR
    Diagn Microbiol Infect Dis; 2009 Dec; 65(4):379-83. PubMed ID: 19775846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals.
    Ewers C; Grobbel M; Stamm I; Kopp PA; Diehl I; Semmler T; Fruth A; Beutlich J; Guerra B; Wieler LH; Guenther S
    J Antimicrob Chemother; 2010 Apr; 65(4):651-60. PubMed ID: 20118165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Within-lineage variability of ST131 Escherichia coli isolates from humans and companion animals in the south of Europe.
    Pomba C; López-Cerero L; Bellido M; Serrano L; Belas A; Couto N; Cavaco-Silva P; Rodríguez-Baño J; Pascual A
    J Antimicrob Chemother; 2014 Jan; 69(1):271-3. PubMed ID: 24022069
    [No Abstract]   [Full Text] [Related]  

  • 33. ESBL- and plasmidic class C beta-lactamase-producing E. coli strains isolated from poultry, pig and rabbit farms.
    Blanc V; Mesa R; Saco M; Lavilla S; Prats G; Miró E; Navarro F; Cortés P; Llagostera M
    Vet Microbiol; 2006 Dec; 118(3-4):299-304. PubMed ID: 16973308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CTX-M-15-producing Escherichia coli clone B2-O25b-ST131 and Klebsiella spp. isolates in municipal wastewater treatment plant effluents.
    Dolejska M; Frolkova P; Florek M; Jamborova I; Purgertova M; Kutilova I; Cizek A; Guenther S; Literak I
    J Antimicrob Chemother; 2011 Dec; 66(12):2784-90. PubMed ID: 21954457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia.
    Severin JA; Mertaniasih NM; Kuntaman K; Lestari ES; Purwanta M; Lemmens-Den Toom N; Duerink DO; Hadi U; van Belkum A; Verbrugh HA; Goessens WH;
    J Antimicrob Chemother; 2010 Mar; 65(3):465-9. PubMed ID: 20053690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence of CTX-M-1-producing Escherichia coli in pigs treated with ceftiofur.
    Jørgensen CJ; Cavaco LM; Hasman H; Emborg HD; Guardabassi L
    J Antimicrob Chemother; 2007 May; 59(5):1040-2. PubMed ID: 17376790
    [No Abstract]   [Full Text] [Related]  

  • 37. Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway.
    Naseer U; Haldorsen B; Simonsen GS; Sundsfjord A
    Clin Microbiol Infect; 2010 Feb; 16(2):171-8. PubMed ID: 19548922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence of extended-spectrum β-lactamase-producing Escherichia coli in wild geese.
    Garmyn A; Haesebrouck F; Hellebuyck T; Smet A; Pasmans F; Butaye P; Martel A
    J Antimicrob Chemother; 2011 Jul; 66(7):1643-4. PubMed ID: 21467083
    [No Abstract]   [Full Text] [Related]  

  • 39. Characteristics of infections caused by extended-spectrum β-lactamase-producing Escherichia coli from community hospitals in South Africa.
    Peirano G; van Greune CH; Pitout JD
    Diagn Microbiol Infect Dis; 2011 Apr; 69(4):449-53. PubMed ID: 21396544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
    Briñas L; Lantero M; de Diego I; Alvarez M; Zarazaga M; Torres C
    J Antimicrob Chemother; 2005 Dec; 56(6):1107-10. PubMed ID: 16239288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.